Search

everythinglearnresearchcommunity

for

Search:↓

New biomarkers and potential treatments for skin diseases were identified.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Plucked hair follicles can help diagnose scalp lupus.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Mice with autoimmune hair loss showed signs of heart problems.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

CD2 might be a new treatment target for patchy alopecia areata.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The plant extract mixture improves skin health by reducing inflammation, boosting collagen, and supporting anti-aging.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Higher cholesterol levels increase aggressive prostate cancer risk.